Method Article

Identifying Kinase Inhibitors that Modulate the Thymocyte Response to Strong TCR Signals

July 8th, 2025

In This Article

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Source: Chen, E. W., et al. Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries. J. Vis. Exp. (2019).

In this video, we describe a method to identify the small-molecule kinase inhibitors that modulate the apoptosis of self-reactive CD4+CD8+ double-positive immature thymocytes. Apoptosis is induced in the double-positive thymocytes by activating them with anti-CD3- and anti-CD28-coated magnetic beads; this is followed by a small-molecule inhibitor treatment and flow cytometry analysis to detect if the inhibitors modulate the apoptotic marker expression.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board.

1. Kinase Inhibitor Library Screening (Centrifuge-independent Assay)

  1. Treatment of thymocytes with kinase inhibitors
    1. Prepare a thymocyte suspension.
    2. Dilute the thymocytes in complete RPMI to obtain a thymocyte suspension of 25 x 106 cells/mL.
    3. Add 40 μL of thymocytes to each well of a small-volume plate, using a multichannel pipette. Place the plate on ice.
    4. Dilute the inhibitors from the stock plate, DMSO, and dexamethasone in complete RPMI at a ratio of four parts of complete RPMI to one part of inhibitor/DMSO/dexamethasone (dilution factor of 5).
      NOTE: As the volumes used in this small-volume plate are 5x smaller than in the conventional method, the inhibitors and the control reagents are diluted fivefold before adding them to the thymocytes in the plate.
    5. Add 0.5 μL of kinase inhibitors to the 96-well plate from the corresponding wells of the inhibitor plate prepared in step 1.1.4.
    6. Prepare eight wells of untreated controls. Prepare four wells of vehicle-treated controls by adding 0.5 μL of the DMSO prepared in step 1.1.4. Prepare four wells of 5 μM dexamethasone-treated controls, using the diluted dexamethasone prepared in step 1.1.4 (Figure 1).

2. Stimulation of thymocytes using anti-CD3/CD28 beads

  1. Make sure that the beads are uniformly resuspended. Take 1 mL of beads and wash them with 2 mL of PBS. Separate the beads using a magnetic stand and aspirate the solution. Resuspend the beads in 1 mL of complete RPMI.
    NOTE: The ratio of beads to cells is 1 to 2.5. Adjust the amount of beads, depending on the number of wells to stimulate and the number of thymocytes used.
  2. Add 10 μL of bead suspension to each inhibitor-treated sample, the four DMSO-treated samples, and four of the eight untreated samples. Add 10 μL of complete RPMI to the remaining four untreated wells. Figure 1 shows the general plate layout.
    NOTE: The final volume of the wells is 50 μL, which is within the maximum capacity of the wells. It is important to exercise caution and to hold the plates upright, to avoid cross-well spillage.
  3. To mix, agitate the plate using a microplate orbital shaker. Alternatively, mix the contents of the wells using a multichannel pipette.
  4. Incubate the thymocytes in a 37 °C, 5% CO2 incubator for 17 - 20 h (or overnight) with an anti-evaporation lid.

3. Setup of the plate washer

NOTE: The instructions for setting up the plate washer are provided by the manufacturer. The steps are mentioned in brief below. Roughly 150 mL of solution is needed for each priming step.

  1. Prime the wash system with 70% ethanol containing 1% Tween 20.
  2. Prime the wash system with deionized water containing 1% Tween 20.
  3. Prime the wash system with FACS wash buffer.

4. Staining of surface antigens

  1. Prepare an antibody staining mixture containing anti-TCRβ, anti-CD4, anti-CD8, and anti-CD69 antibodies. Dilute the antibodies in FACS wash buffer at a ratio of 1:100 (v/v).
  2. Wash the plate 9x, using 55 μL of FACS wash buffer per wash, using the automated laminar flow washing system.
    NOTE: At the end of the washes, there will be 25 μL of residual volume in each well.
  3. Resuspend the cells in 25 μL of the staining antibody mixture prepared in step 1.4.1.
  4. If the samples are transferred from a 96-well plate, resuspend the cells in 50 μL of the antibody mixture, and transfer the samples to the small-volume plate. This step corresponds to method number 2, as depicted in Figure 2A.
  5. To mix, agitate the plate with a microplate orbital shaker or mix the samples using a multichannel pipette, and incubate on ice for 30 min.

5. Fixation of cells

  1. Wash the plate 9x, using 55 μL of FACS wash buffer per wash, using the automated laminar flow washing system.
  2. Add fixation/permeabilization buffer (comes with the active caspase-3 apoptosis kit; same with the 10x perm/wash buffer mentioned in step 1.6.1 and the anti-caspase-3 antibody in step 1.6.2) at 50 μL per well.
  3. Incubate on ice for 30 min.

6. Intracellular staining for active caspase 3

  1. Prepare 1x perm/wash buffer by diluting 25 mL of 10x perm/wash buffer in 225 mL of ultrapure water.
  2. Prepare intracellular active caspase stain by adding 1 mL of anti-caspase-3 antibody to 2 mL of 1x perm/wash buffer. The ratio of antibody to perm/wash buffer is 1:2.
  3. Prime the wash system with 1x perm/wash buffer.
  4. Wash the plate 9x with 1x perm/wash buffer, at 55 μL for each wash.
  5. Add 25 μL of the intracellular caspase stain prepared in step 1.6.2 to all wells.
  6. To mix, agitate the plate with a microplate orbital shaker or mix the samples using a multichannel pipette, and incubate on ice for 1 h.
  7. Wash the plate 9x with 1x perm/wash buffer, at 55 μL for each wash.
  8. Add 25 μL of FACS wash buffer to all wells.
  9. Transfer the samples to microtiter tubes after adequate mixing via pipetting.
  10. Add another 50 μL of FACS wash buffer to the empty wells and repeat step 1.6.9.
  11. Repeat steps 1.6.9 and 1.6.10 2x until 200 μL of the samples are collected in the microtiter tubes.
    NOTE: The purpose of the procedures described in steps 1.6.10 and 1.6.11 is to ensure maximum recovery of the cells from the small-volume plate. If cell numbers are not a concern, after step 1.6.10, simply top up the microtiter tubes to 200 μL with FACS wash buffer.
  12. Run a flow cytometric analysis of the samples and analyze the results with a FACS analysis program. Caspase-3 activation and CD69 expression are analyzed in the gate containing CD4+CD8+DP thymocytes.

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

96-well plate flow cytometry diagram; CD3/CD28 activation, inhibitor effects on CD4/CD8 markers.
Figure 1: Plate layout of the thymocyte activation assay. (Top) Columns 1 and 12 are reserved for controls, while columns 2 to 11 are inhibitor-treated samples (beige). The negative control (nonstimulated [NS]; grey) occupies wells A1 to D1, and the positive control for cell death (dexamet...

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
No conflicts of interest declared.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
RPMIHyCloneSH30027FS
FBSHyCloneSH3007103
L-GlutamineHyCloneSH3003401
Sodium pyruvateHyCloneSH3023901
10X PBS Vivantis PB0344 – 1L
Kinase Screening Library (96-Well)Cayman Chemical10505Exact contents of the library may vary
DMSOSigma AldrichD2650
DexamethasoneSigma AldrichD4902
anti-CD3/CD28 beadsThermo Fisher Scientific11452D
FITC Active Caspase-3 Apoptosis KitBD Pharmingen550480Contains Fixation/Permeabilization buffer, 10X Perm/Wash buffer and anti-caspase 3 antibody
DA-Cell Washer CURIOX HT1000
96-well DA-Cell PlateCURIOX96-DC-CL-05
Antibodies
CD3e BioLegend 100236
TCRbBD Biosciences553174
CD4BD Biosciences740007
CD8BD Biosciences563786
CD69eBioscience25-0699-42
Inhibitors
TG003Cayman ChemicalFrom the Kinase Screening Library
TG003Cayman Chemical-From the Kinase Screening Library
PKC 412Cayman Chemical-From the Kinase Screening Library
DoramapimodCayman Chemical-From the Kinase Screening Library
PaclitaxelCayman Chemical-From the Kinase Screening Library
ErlotinibCayman Chemical-From the Kinase Screening Library
Necrostatin-5Cayman Chemical-From the Kinase Screening Library
NVP-BEZ235Cayman Chemical-From the Kinase Screening Library
Phthalazinone pyrazoleCayman Chemical-From the Kinase Screening Library
AG-879Cayman Chemical-From the Kinase Screening Library
1-NA-PP1Cayman Chemical-From the Kinase Screening Library
Torin 1Cayman Chemical-From the Kinase Screening Library
Bisindolylmaleimide IICayman Chemical-From the Kinase Screening Library
BIBF 1120Cayman Chemical-From the Kinase Screening Library
SMI-4aCayman Chemical-From the Kinase Screening Library
Bisindolylmaleimide XI (hydrochloride)Cayman Chemical-From the Kinase Screening Library
CAY10657Cayman Chemical-From the Kinase Screening Library
AS-703026Cayman Chemical-From the Kinase Screening Library
Chelerythrine chlorideCayman Chemical-From the Kinase Screening Library
TunicamycinCayman Chemical-From the Kinase Screening Library
GSK 1059615Cayman Chemical-From the Kinase Screening Library
RuxolitinibCayman Chemical-From the Kinase Screening Library
Necrostatin-1Cayman Chemical-From the Kinase Screening Library
SB 505124Cayman Chemical-From the Kinase Screening Library
INK128Cayman Chemical-From the Kinase Screening Library
Canertinib (hydrochloride)Cayman Chemical-From the Kinase Screening Library
SB 431542Cayman Chemical-From the Kinase Screening Library
PD 173074Cayman Chemical-From the Kinase Screening Library
Valproic Acid (sodium salt)Cayman Chemical-From the Kinase Screening Library
PD 0325901Cayman Chemical-From the Kinase Screening Library
SB 203580Cayman Chemical-From the Kinase Screening Library
VX-702Cayman Chemical-From the Kinase Screening Library
EmodinCayman Chemical-From the Kinase Screening Library
CHIR99021Cayman Chemical-From the Kinase Screening Library
BIOCayman Chemical-From the Kinase Screening Library
Imatinib (mesylate)Cayman Chemical-From the Kinase Screening Library
Sunitinib MalateCayman Chemical-From the Kinase Screening Library
GefitinibCayman Chemical-From the Kinase Screening Library
PP2Cayman Chemical-From the Kinase Screening Library
3-MethyladenineCayman Chemical-From the Kinase Screening Library
Bisindolylmaleimide ICayman Chemical-From the Kinase Screening Library
Bisindolylmaleimide IVCayman Chemical-From the Kinase Screening Library
Bisindolylmaleimide VCayman Chemical-From the Kinase Screening Library
NSC 663284Cayman Chemical-From the Kinase Screening Library
D 4476Cayman Chemical-From the Kinase Screening Library
NU 7026Cayman Chemical-From the Kinase Screening Library
H-9 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
Indirubin-3'-monoximeCayman Chemical-From the Kinase Screening Library
KN-62Cayman Chemical-From the Kinase Screening Library
KN-93Cayman Chemical-From the Kinase Screening Library
CGP 57380Cayman Chemical-From the Kinase Screening Library
Iso-OlomoucineCayman Chemical-From the Kinase Screening Library
(S)-Glycyl-H-1152 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
Bisindolylmaleimide VIII (acetate)Cayman Chemical-From the Kinase Screening Library
ST638Cayman Chemical-From the Kinase Screening Library
SU 6656Cayman Chemical-From the Kinase Screening Library
LY364947Cayman Chemical-From the Kinase Screening Library
SB 203580 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
CAY10621Cayman Chemical-From the Kinase Screening Library
YM-201636Cayman Chemical-From the Kinase Screening Library
ZM 447439Cayman Chemical-From the Kinase Screening Library
AS-041164Cayman Chemical-From the Kinase Screening Library
NVP-AEW541 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
PP242Cayman Chemical-From the Kinase Screening Library
ABT-869Cayman Chemical-From the Kinase Screening Library
CAY10622Cayman Chemical-From the Kinase Screening Library
17β-hydroxy WortmanninCayman Chemical-From the Kinase Screening Library
CAY10626Cayman Chemical-From the Kinase Screening Library
SU 6668Cayman Chemical-From the Kinase Screening Library
CAY10572Cayman Chemical-From the Kinase Screening Library
N,N-DimethylsphingosineCayman Chemical-From the Kinase Screening Library
LY294002Cayman Chemical-From the Kinase Screening Library
U-0126Cayman Chemical-From the Kinase Screening Library
StaurosporineCayman Chemical-From the Kinase Screening Library
KN-92 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
AS-605240 (potassium salt)Cayman Chemical-From the Kinase Screening Library
O-1918Cayman Chemical-From the Kinase Screening Library
Y-27632 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
LeelamineCayman Chemical-From the Kinase Screening Library
PD 98059Cayman Chemical-From the Kinase Screening Library
PD 169316Cayman Chemical-From the Kinase Screening Library
TGX-221Cayman Chemical-From the Kinase Screening Library
(S)-H-1152 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
AS-605240Cayman Chemical-From the Kinase Screening Library
D-erythro-Sphingosine C-18Cayman Chemical-From the Kinase Screening Library
OSU03012Cayman Chemical-From the Kinase Screening Library
JNJ-10198409Cayman Chemical-From the Kinase Screening Library
Leelamine (hydrochloride)Cayman Chemical-From the Kinase Screening Library
Arachidonic Acid LeelamideCayman Chemical-From the Kinase Screening Library
Lauric Acid LeelamideCayman Chemical-From the Kinase Screening Library
AS-252424Cayman Chemical-From the Kinase Screening Library
CAY10505Cayman Chemical-From the Kinase Screening Library
PI-103Cayman Chemical-From the Kinase Screening Library
PIK-75 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
Sphingosine Kinase Inhibitor 2Cayman Chemical-From the Kinase Screening Library
PiceatannolCayman Chemical-From the Kinase Screening Library
SC-1Cayman Chemical-From the Kinase Screening Library
(R)-RoscovitineCayman Chemical-From the Kinase Screening Library
BAY-43-9006Cayman Chemical-From the Kinase Screening Library
CAY10561Cayman Chemical-From the Kinase Screening Library
AS-604850Cayman Chemical-From the Kinase Screening Library
PI3-Kinase α Inhibitor 2Cayman Chemical-From the Kinase Screening Library
ML-9Cayman Chemical-From the Kinase Screening Library
TriciribineCayman Chemical-From the Kinase Screening Library
Erbstatin AnalogCayman Chemical-From the Kinase Screening Library
KenpaulloneCayman Chemical-From the Kinase Screening Library
OlomoucineCayman Chemical-From the Kinase Screening Library
AG-494Cayman Chemical-From the Kinase Screening Library
AG-825Cayman Chemical-From the Kinase Screening Library
AG-1478Cayman Chemical-From the Kinase Screening Library
SB 216763Cayman Chemical-From the Kinase Screening Library
SB 415286Cayman Chemical-From the Kinase Screening Library
AG-17Cayman Chemical-From the Kinase Screening Library
H-8 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
LFM-A13Cayman Chemical-From the Kinase Screening Library
SC-514Cayman Chemical-From the Kinase Screening Library
ApigeninCayman Chemical-From the Kinase Screening Library
AG-18Cayman Chemical-From the Kinase Screening Library
CAY10554Cayman Chemical-From the Kinase Screening Library
DRBCayman Chemical-From the Kinase Screening Library
RG-13022Cayman Chemical-From the Kinase Screening Library
RG-14620Cayman Chemical-From the Kinase Screening Library
AG-490Cayman Chemical-From the Kinase Screening Library
AG-82Cayman Chemical-From the Kinase Screening Library
AG-99Cayman Chemical-From the Kinase Screening Library
AG-213Cayman Chemical-From the Kinase Screening Library
AG-183Cayman Chemical-From the Kinase Screening Library
Lavendustin CCayman Chemical-From the Kinase Screening Library
ZM 336372Cayman Chemical-From the Kinase Screening Library
5-IodotubercidinCayman Chemical-From the Kinase Screening Library
SB 202190Cayman Chemical-From the Kinase Screening Library
CAY10571Cayman Chemical-From the Kinase Screening Library
NilotinibCayman Chemical-From the Kinase Screening Library
SP 600125Cayman Chemical-From the Kinase Screening Library
L-threo-Sphingosine C-18Cayman Chemical-From the Kinase Screening Library
H-89Cayman Chemical-From the Kinase Screening Library
HA-1077 (hydrochloride)Cayman Chemical-From the Kinase Screening Library
AG-370Cayman Chemical-From the Kinase Screening Library
WortmanninCayman Chemical-From the Kinase Screening Library
AG-1296Cayman Chemical-From the Kinase Screening Library
KT 5823Cayman Chemical-From the Kinase Screening Library
Janex 1Cayman Chemical-From the Kinase Screening Library
CAY10574Cayman Chemical-From the Kinase Screening Library
CAY10575Cayman Chemical-From the Kinase Screening Library
CAY10576Cayman Chemical-From the Kinase Screening Library
NH125Cayman Chemical-From the Kinase Screening Library
TWS119Cayman Chemical-From the Kinase Screening Library
NSC 210902Cayman Chemical-From the Kinase Screening Library
CAY10577Cayman Chemical-From the Kinase Screening Library
CAY10578Cayman Chemical-From the Kinase Screening Library
PD 184161Cayman Chemical-From the Kinase Screening Library
CCT018159Cayman Chemical-From the Kinase Screening Library
MyricetinCayman Chemical-From the Kinase Screening Library

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Thymocyte ApoptosisTCR SignalingFlow CytometryCaspase 3 ActivationCD69 ExpressionMagnetic BeadsAnti CD3 Anti CD28Cell StimulationFACS Analysis

Related Articles